Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth
- 2 April 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 394 (2), 297-302
- https://doi.org/10.1016/j.bbrc.2010.02.164
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- HDAC6 Regulates Androgen Receptor Hypersensitivity and Nuclear Localization via Modulating Hsp90 Acetylation in Castration-Resistant Prostate CancerMolecular Endocrinology, 2009
- A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude MiceCancer Research, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Androgen Receptor in Prostate CancerEndocrine Reviews, 2004
- Molecular action of androgensMolecular and Cellular Endocrinology, 2002
- Molecular Biology of the Androgen ReceptorJournal of Clinical Oncology, 2002
- Hormone Therapy in Advanced Prostate CancerFrontiers of radiation therapy and oncology, 2002
- Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexesThe EMBO Journal, 1999
- Androgen Receptor: An OverviewCritical Reviews™ in Eukaryotic Gene Expression, 1995
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966